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Abstract
Background: Atherosclerosis is still the leading cause of death in the western world. Besides
known risk factors studies demonstrating Chlamydophila pneumoniae (C. pneumoniae) to be
implicated in the progression of the disease, little is known about C. pneumoniae infection dynamics.
We investigated whether C. pneumoniae induce cell death of human aortic endothelial cells, a cell
type involved in the initiation of atherosclerosis, and whether chlamydial spots derive from
inclusions.
Results: Lactate dehydrogenase release revealed host cell death to be dependent on the amounts
of Chlamydia used for infection. The morphology of lysed human aortic endothelial cells showed
DNA strand breaks simultaneously with cell membrane damage exclusively in cells carrying
Chlamydia as spots. Further ultrastructural analysis revealed additional organelle dilation, leading to
the definition as aponecrotic cell death of endothelial cells. Exclusive staining of the metabolic active
pathogens by chlamydial heat shock protein 60 labelling and ceramide incorporation demonstrated
that the bacteria responsible for the induction of aponecrosis had resided in former inclusions.
Furthermore, a strong pro-inflammatory molecule, high mobility group box protein 1, was shown
to be released from aponecrotic host cells.
Conclusion: From the data it can be concluded that aponecrosis inducing C. pneumoniae stem
from inclusions, since metabolically active bacterial spots are strongly associated with aponecrosis
late in the infectious cycle in vascular endothelial cells and metabolic activity was exclusively located
inside of inclusions in intact cells. Vice versa initial spot-like infection with metabolically inert
bacteria does not have an effect on cell death induction. Hence, C. pneumoniae infection can
contribute to atherosclerosis by initial endothelial damage.
Background
Chlamydiae  are obligate intracellular bacteria with a
biphasic developmental life cycle characterised by an
alternation between two morphologically distinct forms,
the elementary body (EB) and the reticulate body (RB)
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[1,2]. The metabolically inert, infectious EBs attach to the
host cell and induce their own uptake.
Upon endocytosis the bacteria remain inside an inclusion
that avoids fusion with host cell lysosomes. Here the
infectious EBs differentiate into RBs, the metabolically
active and replicative form. RBs actively parasitize host
cell nutrients. In the inclusion, bacteria replicate and
intercept exocytic vesicles released from the trans-Golgi or
endoplasmic reticulum. Studies have shown that inclu-
sions containing Chlamydia trachomatis fuse with vesicles
containing sphingomyelin which is incorporated into the
inclusion membrane [3]. At the end of the developmental
cycle, which ranges between 36 – 72 depending on
chlamydial species, chlamydia are released either through
cytolysis or by a process of extrusion that leaves the host
cell intact [4,5].
Chlamydia are known to inhibit host cell apoptosis [6] in
many experimental systems but pro-apoptotic activities
have been described. Here the fate of the host cells in
Chlamydia infections has been reported to be either cas-
pase independent apoptosis [7,8] or aponecrosis [9] or a
mixture of apoptosis and necrosis in a population of cells
[10]. The cell death pathway of the infected cell popula-
tion depends on host cell type, Chlamydia  species and
experimental procedures used. High mobility group box 1
(HMGB1), an architectural nuclear binding factor, is
secreted during necrosis exclusively and has strong pro-
inflammatory properties [11]. It was shown to be released
upon Chlamydia trachomatis infection from HeLa cells and
fresh mouse embryonic fibroblasts to different extents
[12]. Recent studies show its potential involvement in
atherosclerosis acting as a critical mediator of lethal
inflammation [13,14].
Although inclusion formation by Chlamydia  has been
described for a long time, recent publications show an
alternative morphology of Chlamydia infection in cells of
the vascular system. Additional to inclusion formation
(round or oval shaped vesicles) the occurrence of Chlamy-
dia spots (bacterial signal at the resolution limit of the
microscope) and aggregates (irregular shaped aggregated
spots) has been described in human aortic smooth muscle
cells [9] and human aortic endothelial cells [10]. How-
ever, nature of the bacteria residing inside of the host cells
as spots, in terms of metabolic activity and protein expres-
sion needs to be elucidated. It was shown that aponecrotic
human aortic smooth muscle cells exclusively carried
chlamydial spots and/or aggregates, but it remains unclear
whether these spots induce host cell death or are innocent
bystanders.
It has long been known that Chlamydia residing in inclu-
sions of around 4 μm or larger prevent the host cells from
undergoing apoptosis [15-17]. Though the molecular
mechanisms are not fully understood, some mechanisms
have been analyzed. For example, the activity and stability
of IAPs, whose levels are regulated by Chlamydia trachom-
atis during the process of infection, cause resistance to
TNF-α-induced apoptosis [18]. Moreover, the infection
with C. trachomatis leads to a proteasomal degradation of
the BH3-only proteins, initiators of apoptosis [19]. Apop-
tosis prevention in cells carrying chlamydial spots was
never investigated, but is relatively improbable since even
inclusions need a minimal size to prevent apoptosis.
Despite an ongoing critical debate over the causative role
of Chlamydia in atherosclerosis [20], studies have demon-
strated that in addition to the classical risk factors, infec-
tious microorganisms such as C. pneumoniae are
implicated in the progression of the disease [21-23]. As
HAEC can be productively infected by C. pneumoniae [24],
it could contribute to initial endothelial damage by
destroying the host cell.
The earliest event in atherosclerosis is represented by an
endothelial dysfunction resulting from damage by classi-
cal risk factors like smoking, high blood cholesterol etc.
[23]. Starting from the endothelial dysfunction, a com-
plex cascade of events is initiated in the atherosclerotic
process, finally leading to destruction of the vascular wall
by an immune response against as yet unknown antigens
[22,23]. A single layer of HAEC lines the inner compart-
ment of the arterial wall, the intima. Endothelial cells play
a crucial role in maintaining the homeostasis of the vessel
wall and controlling the passage of lymphocytes and lipo-
proteins. Damage to endothelial cells by chlamydial infec-
tion would not only destroy the barrier, it would lead to
release of the pathogen and bacterial products e.g.
chlamydial heat shock protein 60 (cHsp 60). known to be
a T-cell target [22,25,26]. Such a T-cell response might
contribute to atherosclerotic progression.
In this study, we analyzed the demise of HAEC induced by
C. pneumoniae, including the release of HMGB1 at the
level of the individual cell in order to elucidate whether
the pathogen might contribute to the initial endothelial
damage occurring in atherosclerosis. We investigated
whether HMGB1 is released from dead infected HAEC. In
addition, we analyzed whether cell death is induced by C.
pneumoniae-spots that derive from former inclusions.
Results
C. pneumoniae lyse HAEC in a dose-dependent manner
Recent studies showed C. pneumoniae induced lysis of
human aortic smooth muscle cells in a dose-dependent
manner [9]. In order to examine the lytic capability of C.
pneumoniae on HAEC, cells were infected with serial dilu-
tions of C. pneumoniae.BMC Microbiology 2008, 8:32 http://www.biomedcentral.com/1471-2180/8/32
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All cells challenged with C. pneumoniae carried at least one
chlamydial spot. The ratio between cells carrying inclu-
sions and cells carrying spots increased dependent on the
initial infectious dose as analyzed 48 hours post infection
(hpi) from 8.1 +/- 3.5 at 2 IFU/cell to 15.6 +/- 3.3 at 10
IFU/cell for example. The ratio decreased from 48 hpi to
72 hpi when smaller amounts of C. pneumoniae were used
for infection like 2 IFU/cell (8.1 +/- 3.5 to 1.8 +/- 0.7).
LDH release was analyzed 24 h, 48 h and 72 hpi. Chlo-
ramphenicol treated infected cells were used as controls.
A clear dose-dependent host cell lysis was evident
throughout the whole infection cycle (24 h, 48 h and 72
hpi). A representative example at 48 hpi is shown (Fig. 1).
In contrast, infected HAEC treated with chloramphenicol
showed no specific host cell lysis at all time points ana-
lyzed (Fig. 1; 48 hpi), thus excluding a cytotoxic effect of
the bacteria in the initial infection.
Membrane damage and DNA strand breaks occur 
simultaneously only in spot-like infected HAEC
Detection of DNA strand breaks by specific TUNEL stain-
ing together with assessment of membrane integrity by
NHS-biotin staining labelling allows a distinction
between apoptosis and necrosis using confocal laser scan-
ning microscopy [27]. Necrotic cells show a cytoplasmic
NHS-biotin staining due to permeable cell membrane but
lack TUNEL staining of nuclei. Cells in early phases of
apoptosis exhibit TUNEL positive nuclei with condensed
and fragmented chromatin and the cytoplasm is NHS-
negative due to the intact cell membrane. In late phases of
apoptosis TUNEL positive nuclei occur together with
NHS-biotin positive cytoplasm [27].
In order to further characterize Chlamydia  induced cell
death at the single cell level, TUNEL and NHS staining was
compared to C. pneumoniae morphology.
HAEC were infected with C. pneumoniae at 2-fold dilu-
tions ranging from 2 to 40 IFU/cell or additionally treated
with chloramphenicol. C. pneumoniae infected HAEC dis-
played different labelling patterns. Cells carrying both
inclusions and spots always exhibited normal chromatin
labelling and no TUNEL and NHS-biotin staining (Fig.
2A). Numerous HAEC showed a spot-like infection. These
cells exhibited either normal chromatin structure and
unaffected membranes with no TUNEL and NHS-biotin
labelling (not shown) or a TUNEL positive nucleus with
condensed chromatin together with a NHS-positive
labelled cytoplasm (Fig. 2B). Few spots and no inclusions
were found in C. pneumoniae infected HAEC treated with
chloramphenicol, implying the bacteria are able to infect
but fail to replicate. These chloramphenicol treated cells
displayed normal shaped nuclei and intact cell mem-
branes (Fig. 2C). In contrast, non infected HAEC had
round to oval shaped nuclei containing dispersed chro-
matin which was always TUNEL negative, and NHS-biotin
was exclusively located on the surface of the cells, a meas-
ure of intact cell membranes (Fig. 2D). Quantitative anal-
ysis of the different cell death morphologies is
demonstrated in Fig. 2G. The proportion of single NHS-
biotin positive cells was similar among different C. pneu-
moniae concentrations and given time points (Fig. 2G I,
III, V), and was similar among the corresponding chlo-
ramphenicol treated cells HAEC (Fig. 2G II, IV, VI) sug-
gesting no Chlamydia driven necrosis induction. Higher
numbers of NHS-biotin positive untreated cells compared
to treated cells over time might reflect late aponecrotic
cells with completely degraded nuclei that have not been
digested by neighbouring cells. In contrast, TUNEL
together with NHS-biotin labelled HAEC showed a dose
dependent increase at all three time points analyzed (Fig.
2G I, III, V). The number of double positive cells under
chloramphenicol treatment was considerably lower com-
pared to corresponding infected cells (Fig. 2G II, IV, VI),
indicative of Chlamydia driven cell death. The few non
infected cells showing both TUNEL and NHS-biotin label-
ling refer to HAEC undergoing late phases of spontaneous
apoptosis. Single tunnel positive cells occurred only very
rarely amongst chloramphenicol treated cells and in the
infected population and reflect spontaneous apoptosis
Lytic capability of C. pneumoniae Figure 1
Lytic capability of C. pneumoniae. HAEC were infected 
or additionally treated with chloramphenicol. LDH release 
was analyzed in three independent experiments 24 h, 48 h 
and 72 hpi and mean chlamydial induced specific lysis was cal-
culated. Mean and SD (N = 3) at 48 hpi is shown. Significant 
differences are indicated if p < 0.05 as calculated by students 
t-test. C. pneumoniae specific lysis of HAEC is dose depend-
ent and reaches a plateau at 20 IFU/cell. In contrast chloram-
phenicol treated infected HAEC were not lysed.BMC Microbiology 2008, 8:32 http://www.biomedcentral.com/1471-2180/8/32
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Cell death morphology of C. pneumoniae infected HAEC Figure 2
Cell death morphology of C. pneumoniae infected HAEC. HAEC were infected with C. pneumoniae (A, B, C, E, F) or additionally treated with chlo-
ramphenicol (C) or left uninfected (D). C. pneumoniae were detected with anti C. pneumoniae-MOMP (green), DNA strand breaks with TUNEL (red), cyto-
plasm with NHS-biotin (yellow) and DNA of bacteria and host cells with DAPI (blue). Cells in random fields were counted (n = 200) and the percentage of 
NHS-biotin-TUNEL positive cells was calculated (G, H). A: HAEC infected with 20 IFU/cell 48 hpi displaying normal nuclear morphology and two MOMP 
positive inclusions (asterisks). B: HAEC infected with 20 IFU/cell 48 hpi that show a spot-like infection and TUNEL positive condensed nuclei as well as 
cytoplasmic NHS-biotin signal. C. pneumoniae-MOMP positive spots and aggregates (arrows) are randomly scattered in the cell. C: Chloramphenicol 
treated cells infected with 20 IFU/cell 48 hpi lack TUNEL and NHS-biotin labelling and display a regular nuclear morphology. D: Uninfected HAEC display-
ing a regular nuclear structure without TUNEL and cytoplasmic NHS-biotin label. E: HAEC infected for 24 h with 40 IFU/cell. F: HAEC infected for 72 h 
with 5 IFU/cell. Note that although the cells are infected with different infection doses and fixed at different time points they both elicit the same cell death 
morphology, thus excluding a cytotoxic effect and underlining the independency of cell death morphology from infection time. Scale bar; 10 μm G (left 
panel): The number of double positive cells (NHS-biotin + TUNEL) increases dose dependently. The number of single NHS-biotin positive cells does not 
significantly vary among different infection doses and time points. G (right panel): Chloramphenicol treated infected cells display a lower amount of NHS-
biotin-TUNEL positive cells which is independent of the initial infectious dose compared to untreated cells. H: The number of NHS-biotin-TUNEL positive 
cells increases time dependently in HAEC infected with low infection doses whereas in cells infected with high C. pneumoniae concentrations the number 
of NHS-biotin-TUNEL positive cells decreases over time. One representative experiment out of three is shown.BMC Microbiology 2008, 8:32 http://www.biomedcentral.com/1471-2180/8/32
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(Fig. 2G) which occurs to a smaller extend than in Hep-2
cells (data not shown). These results indicate that C. pneu-
moniae induces neither classical apoptosis nor necrosis,
but that a mixture of apoptotic and necrotic features are
evident on the single cell level. Conclusively, HAEC
infected with low C. pneumoniae concentrations showed a
time dependent increase of TUNEL and NHS-biotin posi-
tive cells. In contrast, cells infected with high C. pneumo-
niae doses displayed a high number of double positive
cells at the beginning of the infection which drastically
decreased until 72 hpi (Fig. 2H). The data suggest that a
minimal level of living Chlamydia needs to be reached,
either through replication or by infection, in order to
induce cell death. This reflects that a small initial infec-
tious dose lead to substantial number of dead cells after
longer time compared to challenge with a high number of
bacteria. However, no differences concerning cell death
morphology among different C. pneumoniae infection tit-
ers or time points were observed (Fig. 2E, F). There is no
difference whether infection occurs with an initially high
or low chlamydial dose and whether analysis is done early
or late in the infectious cycle. Thus, it can be excluded that
this kind of cell death morphology is a cytotoxic effect
caused by high bacterial titres.
Taken together, C. pneumoniae infected HAEC containing
both inclusions and spots always display normal cell mor-
phology. Membrane damage and DNA fragmentation
occurs exclusively in spot and/or aggregate carrying
HAEC.
C. pneumoniae infected HAEC release HMGB1 in a time- 
and dose-dependent manner
The high mobility group box 1 (HMGB1) protein is a
nuclear factor that is released upon necrotic cell death but
not apoptotic cell death [11]. It is as well known that it has
strong pro-inflammatory capacities [28].
HAEC were infected with C. pneumoniae or additionally
treated with chloramphenicol. HMGB1 release was evalu-
ated 24 h, 48 h and 72 hpi and chlamydial infection mor-
phology was followed using confocal laser scanning
microscopy. HAEC bearing both inclusions and spots
always displayed HMGB1 positive nuclei associated with
a regular nuclear morphology (Fig. 3A). In contrast,
HMGB1 negative cells bearing just chlamydial spots or
aggregates showed condensed chromatin in the shrunken
nuclei (Fig. 3B). Despite a high number of spot-like
infected HAEC treated with chloramphenicol all cells
were HMGB1 positive showing a normal nuclear mor-
phology (Fig. 3C). Quantification of HMGB1 negative
nuclei revealed time- and dose-dependent HMGB1 release
(Fig. 3D, E; pooled data out of three experiments)
In order to confirm Chlamydia  induced cell death is
accompanied by HMGB1 release at the single cell level,
infected HAEC were stained in parallel for TUNEL and
NHS-biotin. Infected HAEC which displayed a TUNEL
positive nucleus with condensed chromatin and NHS-
biotin labelled cytoplasm always lacked nuclear HMGB1
staining (Fig. 3F), demonstrating that aponecrotic
infected HAEC indeed release HMGB1. TUNEL positive
and NHS-biotin negative cells, reflecting apoptosis, exhib-
ited HMGB1 positive nuclei with condensed and frag-
mented chromatin (Fig. 3G). In contrast, TUNEL negative
NHS-biotin positive necrotic cells lacked HMGB1 nuclear
labelling (Fig. 3H) as previously described [11]. Non-
infected control cells negative for TUNEL and NHS-biotin,
showed round to oval shaped nuclei containing dispersed
chromatin which was always HMGB1 positive. Finely
scattered granular cytoplasmic HMGB1 was additionally
observed (Fig. 3I). Some TUNEL positive nuclei lacked
HMGB1 staining, reflecting late stages of apoptotic cell
death (data not shown).
C. pneumoniae infection of HAEC causes chromatin 
condensation as well as damage of organelles and cell 
membrane
To further characterize cell death in individual cells,
ultrastructural analysis of infected HAEC assessed by
transmission electron microscopy (TEM) was performed.
Some HAEC harboured large inclusions filled with
numerous reticulate bodies (RB) (Fig. 4A) and elementary
bodies (EB) (not shown). These cells had an intact
nucleus and normal organelle ultrastructure. Dead cells in
infected cultures did not contain inclusions but exhibited
rounded nuclei with condensed heterochromatin and
compact nucleoli as well as dilated organelles and dam-
aged cell membranes (Fig. 4B). Chloramphenicol treated
infected HAEC displayed intact organelles and a regular
nuclear structure. Here, a few single C. pneumoniae could
be detected by TEM (Fig. 4C). In order to confirm the
ultrastructural changes staurosporin, an inducer of classi-
cal apoptosis, and sodium azide, a necrosis inducing
agent, were used. Staurosporin treated HAEC showed con-
densed chromatin and a fragmented nucleus, characteris-
tic features of apoptosis (Fig. 4D). In contrast, necrotic
Na-acide treated cells displayed swollen organelles and a
considerable damage of the cell membrane (Fig. 4E).
Finally, untreated cells displayed an unaltered cell mor-
phology containing an intact nucleus rich in euchroma-
tin. Numerous intact organelles were spread throughout
the cytoplasm (Fig. 4F). In summary, HAEC bearing both
inclusions and spots show unaltered cell ultrastructures
with normally shaped nuclei and organelles. In contrast,
many infected cells bearing no inclusions shared both
apoptotic and necrotic characteristics, namely chromatinBMC Microbiology 2008, 8:32 http://www.biomedcentral.com/1471-2180/8/32
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HMGB1 release in infected HAEC Figure 3
HMGB1 release in infected HAEC. HAEC were infected with 2 IFU/cell C. pneumoniae (A, B) or 20 IFU/cell (C, F) and analyzed 48 hpi (F) or 72 hpi (A, 
B, C). Control cells were additionally treated with chloramphenicol (C), incubated with staurosporin (G), treated with Na-acid (H) or left untreated (I). 
Mean and SD of three pooled experiments are depicted, differences were considered to be significant if p < 0.05 (D, E). Cells were labelled with anti-
MOMP antibody (red), with anti-HMGB1 antibody (green), TUNEL (red), NHS-biotin (yellow), and DAPI (blue). A: Cells containing two inclusions (aster-
isks) and single C. pneumoniae-spots (arrows) display a regular nuclear morphology associated with a strong HMGB1 signal localized in the nucleus. B: 
HAEC harbouring C. pneumoniae-spots (arrows) resp. aggregates (arrow head) display condensed nuclei that have released HMGB1. C: Chloramphenicol 
treated infected HAEC display spots (arrows) together with a strong nuclear HMGB1 signal. D, E: Quantification of HMGB1 negative nuclei revealed a 
time- and dose-dependent HMGB1 release in the course of the Chlamydia infection. Two representative results such as 48 hpi (D) and 10 IFU/cell (E) are 
shown. Additionally labelling for TUNEL and NHS-biotin relates HMGB1 to cell death morphology (F, G, H, I). F: Infected HAEC indicated by DAPI posi-
tive spots (arrows) contain a TUNEL positive but HMGB1 negative, condensed nucleus as well as NHS-biotin positive cytoplasm. G: Apoptotic cells show 
a characteristic fragmentation of the nucleus positive for TUNEL and HMGB1. H: Necrotic cells lack TUNEL and HMGB1 labelling in the nucleus. I: Not 
infected cells display a normal nuclear morphology with a strong nuclear HMGB1 signal. Scale bar; 10 μm; G; 5 μm.BMC Microbiology 2008, 8:32 http://www.biomedcentral.com/1471-2180/8/32
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condensation together with damage of organelles and cell
membrane indicative of aponecrotic cell death.
Metabolic active C. pneumoniae-spots derive from 
inclusions and induce cell death in HAEC late in the 
infection cycle
cHsp60 has been shown to be expressed throughout the
life cycle of Chlamydiae  [29]. Heat shock proteins are
known to function as chaperones for newly synthesized
peptides and have a role in folding and translocation [30].
Although the precise function of cHsp60 is still specula-
tive, it can be used to assess chlamydial metabolic activity
by specific labelling with a monoclonal anti cHsp60 anti-
body [31]. In order to investigate chlamydial metabolic
activity, infected HAEC were labelled for cHsp60 and ana-
lyzed 24 h, 48 h and 72 hpi using confocal laser scanning
microscopy. Co-localization with C. pneumoniae signal
was subsequently analyzed.
cHsp60 signal of infected HAEC harbouring both inclu-
sions and spots predominantly colocalized with the C.
pneumoniae inside the inclusion (Fig. 5A) but not in the
spots. These cells always displayed a normal nuclear mor-
phology as assessed by DAPI staining. In contrast, C. pneu-
moniae-spots in aponecrotic HAEC colocalized with
cHsp60 signal (Fig. 5B). In order to prove cHsp60 is pro-
duced de novo, infected HAEC were treated with chloram-
phenicol. Although many C. pneumoniae-spots occurred,
only few colocalized with cHsp60 compared to untreated
infected dead HAEC (Fig 5C).
Ultrastructure of C. pneumoniae infected HAEC Figure 4
Ultrastructure of C. pneumoniae infected HAEC. Cells were either infected with 10 IFU/cell (A, B) or 32 IFU/cell and treated with chloramphenicol 
(C) and analyzed 24 hpi (B, C) or 48 hpi (A). Control cells were treated with staurosporin (D), Na-acid (E) or were left untreated (F). A: Infected HAEC 
with an inclusion (asterisk) containing numerous reticulate bodies show normal nuclear-, intact organelle and cell membrane morphology. B: Infected 
HAEC undergoing cell death show condensed chromatin and dilated organelles (arrow heads) associated with strong membrane damage. These cells dis-
play apoptotic as well as necrotic features. C: Chloramphenicol treated HAEC with two elementary bodies (arrows) localized in a cell with intact 
organelles, membrane and nucleus. D: Staurosporin treated HAEC showing middle to late stage of apoptosis with a fragmented nucleus containing con-
densed heterochromatin. E: The organelles and the cell membrane of Na-acid treated cells are completely disrupted. F: The nuclei of untreated intact 
HAEC contain finely dispersed euchromatin. Scale bar; 2 μm; C, F; 0,5 μm.BMC Microbiology 2008, 8:32 http://www.biomedcentral.com/1471-2180/8/32
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In order to confirm that C. pneumoniae-spots must have
occupied inclusions to induce cell death, infected HAEC
were incubated with BODIPY FL C5-Ceramide (D3521)
to exclusively label metabolically active Chlamydia. Inclu-
sions are known to intercept the vesicular transport of the
host cell and incorporate bodipy dyes [32]. Infected
HAEC were treated for 24 h with D3521 at 24 h, 48 h and
72 hpi in order to follow fluorescent ceramide incorpora-
tion and distribution throughout the whole infection
cycle. Colocalization of D3521 and C. pneumoniae was
subsequently analyzed
Infected HAEC harbouring inclusions stained with D3521
displayed ceramide labelling in all inclusions (Fig. 6A).
Corresponding samples of spot-like infected intact HAEC
with a regular nuclear structure showed only low amounts
of colocalized D3521 and C. pneumoniae signal in spots
(Fig. 6B), indicating no or very much reduced metabolic
activity of the chlamydial spots. In contrast, many spots of
spot-like infected aponecrotic HAEC colocalized with
D3521 suggesting that these spots had resided in inclu-
sions (Fig. 6C). C. pneumoniae-spots of chloramphenicol
treated infected cells colocalized with D3521 only in spots
that still displayed DNA signal. DNA negative spots never
Detection of chlamydial Hsp60 Figure 5
Detection of chlamydial Hsp60. HAEC were infected with 10 IFU/cell (A, B) or with 20 IFU/cell and additionally treated with chloramphenicol (C). 
Cells were stained with anti C. pneumoniae neat serum (red), anti C. pneumoniae Hsp60 (green), DAPI (blue) and colocalization of cHsp60 and MOMP was 
calculated (white). A: A C. pneumoniae inclusion (asterisk) strongly colocalizes with the cHsp60 signal. In contrast, all C. pneumoniae-spots are negative for 
the cHsp60 signal. B: The nucleus of spot-like infected HAEC is condensed and many chlamydial spots colocalize with cHsp60. C: Chloramphenicol treated 
infected HAEC display a regular nuclear morphology and many C. pneumoniae-spots which predominantly do not colocalize with the cHsp60 signal. Scale 
bar; 10 μm.BMC Microbiology 2008, 8:32 http://www.biomedcentral.com/1471-2180/8/32
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Detection of BODIPY FL C5-Ceramide Figure 6
Detection of BODIPY FL C5-Ceramide. HAEC were infected with 10 IFU/cell for 24 h or 48 h and subsequently incu-
bated with D3521 for 24 h. Controls were additionally treated with chloramphenicol. Cells were stained with anti C. pneumo-
niae-MOMP (red), D3521 (green), DAPI (blue) and colocalization of D3521 and MOMP was calculated (white). A: Infected 
HAEC 72 hpi contain a MOMP positive inclusion (asterisk). B: Spot-like infected healthy HAEC 48 hpi display a number of 
MOMP positive spots (arrows) of which only very few colocalize with the ceramide signal. Hence, 24 h after ceramide supply 
D3521 colocalizes with the MOMP signal in the inclusion but not in the spots of healthy infected host cells (A, B). C: 
Aponecrotic spot-like infected cell 48 hpi display a high number of MOMP positive spots resp. aggregates (arrows). The major-
ity of the C. pneumoniae-spots colocalize with the D3521 signal, reflecting metabolic activity. D: Chloramphenicol treated 
infected HAEC 48 hpi display a normal nuclear morphology and carry a variety of C. pneumoniae-spots. Few of them colocalize 
with D3521. Note that the D3521 signal occurs exclusively in spots displaying a DAPI labelling (arrows). Scale bar; 10 μm.BMC Microbiology 2008, 8:32 http://www.biomedcentral.com/1471-2180/8/32
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colocalized with ceramide signal referring to metaboli-
cally inactive chlamydial particles (Fig. 6D).
Taken together the results show that cHsp60 is produced
exclusively by C. pneumoniae residing inside inclusions.
Furthermore, 24 h after D3521supply, only ceramide pos-
itive inclusions occur, proving that metabolic activity is
localised inside inclusions but not in spots. We never
observed metabolically active aggregates alone, they were
always accompanied by metabolically active spots, hence
excluding the possibility of an aberrant inclusion forma-
tion. These cHsp60 and D3521 positive bacteria are then
released into the cytosol and cause cell death of the host.
These results together with the LDH release suggest that
metabolically active C. pneumoniae-spots that derive from
inclusions induce cell death in HAEC.
Discussion
In the present study we have demonstrated that metabol-
ically active C. pneumoniae stem from inclusions and lead
to aponecrosis in human aortic endothelial cells. Healthy
cells harbour metabolically active C. pneumoniae exclu-
sively in inclusions. Aponecrotic cells, in contrast, display
an infection with scattered metabolically active chlamy-
dial spots or aggregates, indicating bacterial release from
former inclusions.
The release of Chlamydia into the cytosol, largely unno-
ticed during the past, seems to be a conserved mechanism
between different Chlamydia  species and is occurring
under different experimental settings. A remarkable study
was recently published strongly supporting our data. It
was shown that inclusions are lysed by proteases and that
HeLa cells died shortly after release of Chlamydia trachom-
atis into the cytosol by a calcium-dependent cell mem-
brane disruption [5]. Our findings strongly suggest that
also C. pneumoniae is released from inclusions leading to
cell death of the host cell. As metabolic activity is located
only in the inclusions late in the infectious cycle and de
novo synthesis of cHsp60 occurs exclusively in inclusions
it is highly probable that metabolically active scattered
bacteria in dead cells must have derived from inclusions.
Moreover, the amount of inclusion carrying cells
decreases from 48 hpi to 72 hpi when a small initial infec-
tious dose was used. However, further investigations need
to be done to prove an actual release mechanism. The
question remains open what the molecular factors are that
lead to release of bacteria and cell death. Signals leading
to cell death could be the contact of Chlamydia with pro-
teins in the cytoplasm. Although metabolically active
Chlamydia are released from inclusions, current data do
not allow to determine whether it is the contact of RBs or/
and EBs with the cytoplasm. Another possibility could be
that chlamydial proteins that are released along with the
pathogens during inclusion rupture induce cell death. A
membrane lysing substance targeting preferentially
eukaryotic membranes could induce permeabilization in
major membranous structures. The nature of such pro-
teins putatively involved in cell death induction remains
to be elucidated.
Moreover, treatment of Chlamydia infected cells with chlo-
ramphenicol completely abolished cell death induction.
This indicates that the initial bacterial burden can be
excluded as an initiator of aponecrosis.
Although chlamydial induction of apoptosis was
described in some studies [7,8] strikingly low numbers of
single TUNEL positive cells were observed throughout the
infection cycle in our experiments, a reflection of sponta-
neous apoptosis of residual uninfected cells within the
infected population. It is evident that Chlamydia can influ-
ence cell death in order to successfully end the replication
cycle. However, it is also evident that the nature of
induced cell death is more intricate than a sole activation
of the apoptotic pathway. Depending on different cell
types, chlamydial strains and experimental apoptotic pro-
cedures [7,8], a combination between apoptosis and
necrosis in a cell population [10] and aponecrosis at the
single cell level have been described [9]. In this study,
infected dead HAEC displayed apoptotic features such as
condensation of the chromatin together with necrotic fea-
tures, including early damage to organelles and disruption
of the cell membrane. This morphology was previously
observed also in other cells [9,33] and was termed
aponecrosis. Additionally, we show that cell death mor-
phology does not differ between cells infected with high
infection doses for a short period of time and cells sub-
jected to low infection doses for longer time.
We never observed dead HAEC containing inclusions,
which is in accordance with previous studies showing that
Chlamydia possesses both pro- and anti-apoptotic capabil-
ities [34]. Chlamydia inhibits apoptosis by blocking the
release of cytochrome c through the interaction with pro-
apoptotic agents such as BH3-only proteins and Bax/Bak
[17,19,35]. Other proposed anti-apoptotic strategies are
based on the induction of inhibitor of apoptosis 2 (c-
IAP2) expression [36]. On the other hand, the Chlamydia
protein associating with death domains (CADD) is
involved in caspase-dependent apoptosis [34,37]. Cas-
pase-independent cell death is obviously triggered by
apoptosis-inducing factor (AIF) [10]. Whichever control
mechanisms occur, it shows Chlamydia to have evolved a
highly dynamic regulatory strategy for apoptosis preven-
tion. In our system, aponecrotic HAEC displayed a con-
densed chromatin but no signs of nuclear fragmentation.
Such a different DNA cleavage pattern, compared to apop-
totic nuclei, was also described in other studies performed
with  Chlamydia trachomatis [8] and C. pneumoniae [9].BMC Microbiology 2008, 8:32 http://www.biomedcentral.com/1471-2180/8/32
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Since aponecrotic HAEC contained prior inclusions, it is
probable that the apoptotic process was interfered by
Chlamydia residing in inclusions. Hence, the interrupted
apoptotic cascade together with the release of the bacteria
might cause this particular form of chimeric cell death.
Moreover, aponecrotic cell death was accompanied by a
release of the pro-inflammatory HMGB1 protein. HMGB1
is a multifunctional protein which on one hand binds and
modifies DNA structure to facilitate transcription, replica-
tion and repair [38] and on the other hand acts as a pro-
inflammatory cytokine in the extra cellular milieu [39].
HMGB1 released from damaged endothelium may con-
tribute to inflammatory responses in atherosclerotic
lesions. It has been reported that addition of HMGB1
induces expression of leukocyte adhesion molecules such
as vascular cell adhesion molecule (VCAM-1) and the
release of tumour necrosis factor (TNF) from cultured
microvascular endothelial cells [28]. Up-regulation of
another adhesion molecule, namely intracellular cell
adhesion molecule (ICAM-1), was observed in human
umbilical vein endothelial cells upon Chlamydia infection
[40]. However, HMGB1 also acts as a strong chemotactic
agent for smooth muscle cells [41]. Thus, a damaged
endothelium might induce the migration of SMC into the
intima, another crucial factor in the progression of athero-
sclerosis [42]. These numerous observations indicate that
HMGB1 released from C. pneumoniae infected HAEC may
be a possible mediator and enhancer of local inflamma-
tion and progression of atherosclerosis.
A further strong pro-inflammatory factor that might trig-
ger inflammation in atherosclerotic lesions is cHsp60. We
indeed found cHsp60 predominantly in inclusions and
scattered in aponecrotic HAEC. Beside their function as a
chaperones, bacterial Hsp60 are known to be highly
immunogenic and are able to activate the immune
response [43]. It has been shown that cHsp60 regulates
macrophage tumour necrosis factor α (TNF-α) and matrix
metalloproteinase (MMP) expression and secretion [44]
which in turn could enhance the immune response and
destabilize the atherosclerotic lesion [45]. It has been
additionally reported that immune cells not only interact
with bacterial Hsp60 but also with endogenous Hsp60
expressed by stressed endothelial cells [46]. Conclusively,
C. pneumoniae Hsp60 was observed to directly promote
vascular smooth muscle cell growth [47] and is recog-
nized by T-cells [25,26]. We found Chlamydia expressing
cHsp60 to be spilled from aponecrotic infected HAEC
which raises the possibility of additional aggravation of
the developmenting atherosclerotic lesion.
Although the debate about the potential causative role of
C. pneumoniae in atherosclerosis is still in progress, a clear
association between atherosclerosis and C. pneumoniae
can not be denied [48]. Here we show that metabolically
active C. pneumoniae induce aponecrotic death of a cell
type implicated in the initiation of atherosclerotic lesions.
Due to the resulting membrane disruption of infected
HAEC cellular contents, pro-inflammatory HMGB1 and
cHsp60 expressing bacteria are passively released into the
extra cellular space, thus possibly contributing to the
inflammatory response. Despite considerable advances
concerning chlamydial infection dynamics and induction
of cell death has been done, underlying responsible effec-
tors still have to be elucidated. Besides antibiotic treat-
ment the discovery of such effectors might represent an
alternative target against chlamydial infection.
Conclusion
C. pneumoniae leads in HAEC to cell death with both
apoptotic and necrotic cell death features in vitro.
Aponecrotic cell death is induced by metabolically active
bacteria that are released from inclusions and occur as
spots within the cytoplasm. In contrast, the initial spot-
like morphology of infected healthy cells is an innocent
bystander effect representing metabolically inactive
Chlamydia or bacterial fragments that failed to establish a
proper infection. The inflammatory response elicited in
the wake of infection might induce endothelial dysfunc-
tion and thus additionally contribute to the initiation and
progression of atherosclerosis in vivo.
Methods
Bacteria and host cell lines
Human aortic endothelial cells were purchased from
Cambrex and HEp-2 cells from the American type culture
collection (ATCC). C. pneumoniae strain TWAR CDC/
CWL-029 was kindly provided by G. Christiansen (Insti-
tute of Microbiology and Immunology, University
Aarhus, Denmark). All cells and bacteria were found to be
free from mycoplasma contamination as analyzed by
DAPI staining.
HAEC were cultivated at 37°C and 5% CO2 in endothelial
growth medium (EGM, Cambrex) supplemented with
10% fetal bovine serum (FBS, Invitrogen). HEp-2 cells
were grown in MEM-Eagle (Invitrogen) with 10% FCS
(Invitrogen) and 2 mM glutamine at 37°C and 5% CO2.
HAEC were seeded at 2.4 × 104 cells/cm2 into either 6-, 24-
or 96-well plates (NUNC) coated with 2 μg/cm2 Fibronec-
tin (Chemicon International) one day prior to infection.
Chlamydophila pneumoniae culture and infection of 
HAEC
Chlamydophila pneumoniae was cultured in HEp-2 cells,
purified on a renografin density gradient and the titer was
determined as already described [49].BMC Microbiology 2008, 8:32 http://www.biomedcentral.com/1471-2180/8/32
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HAEC were infected with C. pneumoniae titers between 2
and 40 IFU/cell. Infection in serum free MEM-Eagles
medium was assisted by centrifugation at 1000 × g for 1 h
at room temperature. The medium was subsequently
replaced by EGM + 10% FBS or by EGM + 10% FBS con-
taining 0.1 μg/ml chloramphenicol, which inhibits bacte-
rial protein synthesis, and infected cells were cultured for
24 h, 48 h or 72 h.
Induction of cell death
Apoptosis was induced by the addition of 1 μM stau-
rosporin (Sigma Chemicals) for 4 h in EGM + 10% FBS.
Necrosis was induced by sodium azide (3%) treatment in
EGM + 10% FBS for 15 min.
Lactate dehydrogenase (LDH) release
LDH release was determined using the cytotoxicity detec-
tion kit (Roche) according to the manufacturer's protocol.
Briefly, HAEC were seeded in a 96-well plate one day prior
to infection, infected with serial dilutions of C. pneumo-
niae and cultured in EGM + 3% heat inactivated FBS. LDH
release was analyzed 24 h, 48 h and 72 hpi. Chlamydia
specific HAEC lysis was calculated according to the fol-
lowing formula: [(experimental value – low control)/
(high control – low control)] × 100. Uninfected cells were
used as a negative control (low control) whereas cells
treated with 1 % Triton-X 100 were used as a positive con-
trol (high control).
NHS-, TUNEL-, C. pneumoniae- and DAPI-staining
HAEC monolayers and supernatants were washed in PBS
and labelled for 15 min on ice with 0.1 mg/ml NHS-
biotin (Pierce) in PBS. Cells were subsequently fixed with
3% paraformaldehyde (PFA) + 2% sucrose for 30 min at
room temperature (RT). Fixed cell monolayers were
detached and combined with supernatants. Samples were
cytospun onto glass microscope slides and permeabilized
with 0.2% Triton-X 100 in PBS for 2 min at RT. DNA
strand breaks were stained using the terminal transferase-
kit (Roche) according to the manufacturer's instructions.
Chlamydiae were either labelled by mouse anti-C. pneumo-
niae-MOMP monoclonal antibody (DAKO) 1:50 in 0.5%
BSA in PBS for 1 h at RT. MOMP antibody was detected
with goat anti-mouse Texas Red resp. FITC antibody 1:200
(Jackson Immuno Research) for 1 h at RT. Or Chlamydia
were stained with rabbit anti C. pneumoniae neat serum
(1:50; Cygnus Technology), followed by goat anti rabbit
Texas Red (Jackson Immuno Research) or donkey anti
rabbit biotinylated antibody 1:200 (Jackson Immuno
Research) and by 0.5 μg/ml streptavidin-Cy5. All label-
lings were performed for 1 h at RT. 0.5 μg/ml streptavidin-
Cy5 (Jackson Immuno Research) was used for the detec-
tion of NHS-biotin. DNA was labelled with 1 μg/ml 4', 6-
Diamidin-2'-phenylindoldihydrochlorid (DAPI, Molecu-
lar Probes) for 30 min at RT. The samples were embedded
in fluorescence mounting medium (Dako) and analyzed
on a confocal laser scanning microscope (SP1 or SP5,
Leica).
Transmission electron microscopy (TEM)
HAEC were fixed with 50 mM sodium cacodylate buffer
pH 7.3 containing 0.8% PFA and 2% glutaraldehyde for 5
min at RT and post fixed for 1 h at RT with 2% osmium
tetroxide + 3% potassium ferrocyanide. The cells were
embedded into 2.5% agar in 50 mM sodium cacodylate
buffer pH 7.3, cooled down over night at 4°C and dehy-
drated in an ethanol series. The dehydrated samples were
finally embedded into epon (Catalys) containing 1:1 pro-
pylenoxide for 2 h at RT. Ultra-thin sections of 60 nm
were contrasted with uranyl acetate and potassium citrate
and analyzed using a CM 100 transmission electron
microscope (Phillips).
cHsp60 staining and fluorescent ceramide incorporation
Chlamydial Hsp60 (cHsp60) was detected with mouse
anti cHsp60 monoclonal antibody (Milan Analytica AG)
1:1000 in 0.5% BSA in PBS at 4°C over night. The second-
ary goat anti mouse FITC antibody was diluted 1:200 in
1% BSA in PBS and applied for 1 h at RT.
Metabolic activity of C. pneumoniae was analyzed using
bodipy as already described [32]. In brief, infected cells
were incubated with 2 μM BODIPY FL C5-ceramide
D3521 (Molecular Probes) in EGM + 10% FBS at indi-
cated time points for 24 h at 37°C. Samples were subse-
quently fixed, cytospun and analyzed by confocal
microscopy.
Staining of HMGB1
HAEC were fixed, cytospun and washed in PEM (0.1 M
PIPES, 1 mM EGTA, 0.5 mM MgCl2, pH 6.9). Detection of
high mobility group box 1 (HMGB1) protein was assessed
using rabbit anti HMGB1 polyclonal antibody 1:50
(Abcam) in 1% BSA in PBS over night at 4°C. Goat anti
rabbit FITC antibody 1:200 in 1% BSA in PBS for 1 h at RT
was used for detection of the anti HMGB1 antibody.
Confocal microscopy and image processing
Samples were analyzed on a confocal laser scanning
microscope (SP1 or SP5, Leica). Deconvolution of the
images was performed using Huygens software (SVI).
Colocalization of C. pneumoniae and Hsp60 was analyzed
using Imaris Software (Bitplane).
Volume data concerning NHS-biotin and TUNEL resp.
HMGB1 labelling were evaluated counting with Imaris
(Bitplane) at least 100 cells in random fields.BMC Microbiology 2008, 8:32 http://www.biomedcentral.com/1471-2180/8/32
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